Proto Labs (PRLB) EBITDA (2011 - 2026)

Proto Labs has disclosed EBITDA across 16 years of filings, most recently posting $5.6 million for Q1 2026.

• EBITDA for Q1 2026 came in at $5.6 million, up 19.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.2 million (up 72.75% YoY), and the FY2025 annual result was $28.2 million, up 69.95% from the prior year.
• EBITDA came in at $5.6 million for Q1 2026 at Proto Labs, down from $9.7 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $9.8 million in Q3 2024 to a low of -$102.4 million in Q4 2022.
• The 5-year median for EBITDA is $4.4 million (2024), against an average of -$2.8 million.
• Across the five-year window, EBITDA sank 1297.47% in 2022 and soared 995.67% in 2023, its largest moves.
• Proto Labs' EBITDA stood at -$102.4 million in 2022, then jumped by 109.05% to $9.3 million in 2023, then tumbled by 116.58% to -$1.5 million in 2024, then soared by 734.57% to $9.7 million in 2025, then plunged by 42.55% to $5.6 million in 2026.
• The last three EBITDA figures came in at $5.6 million (Q1 2026), $9.7 million (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.